Predicting the outcome of the ongoing patent disputes surrounding genome-editing technology is equal parts patent analysis and history.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jinek, M. et al. Science 337, 816–821 (2012).
Jinek, M. et al. US Patent Application No. PCT/US2013/032589 (2013).
Cong, L. et al. Science 339, 819–823 (2013).
Zhang, F. US Patent No. 8,697,359 (2014).
Miller, J.C., Rebar, E.J. & Zhang, S.H. US Patent Application No. 2014/0336133 (2014).
35 USC § 135 (2010).
Madey v. Duke University, 357 F.3d 1351 (Fed. Cir. 2002).
35 USC § 271(e) (2012).
35 USC § 103 (2010).
Feldman, M.P. et al. Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices (eds. Krattiger, A. et al.) 1797–1807 (MIHR, Oxford, 2007).
Rojahn, S.Y. Broad Institute gets patent on revolutionary gene-editing method. MIT Technology Review http://www.technologyreview.com/view/526726/broad-institute-gets-patent-on-revolutionary-gene-editing-method/ (2014).
Fore, J. Jr., Wiechers, I.R. & Cook-Deegan, R. J. Biomed. Discov. Collab. 1, 7 (2006).
Acknowledgements
The author would like to thank Christopher Weyant for invaluable contributions to this paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Sherkow, J. Law, history and lessons in the CRISPR patent conflict. Nat Biotechnol 33, 256–257 (2015). https://doi.org/10.1038/nbt.3160
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3160
This article is cited by
-
Nature beyond control: how expectations should inform decisions about human germline engineering
Journal of Assisted Reproduction and Genetics (2019)
-
The rise of the ethical license
Nature Biotechnology (2017)
-
Situating brain regions among patent rights and moral risks
Nature Biotechnology (2017)
-
TILLING by Sequencing (TbyS) for targeted genome mutagenesis in crops
Molecular Breeding (2017)
-
CRISPR: Pursuit of profit poisons collaboration
Nature (2016)